Panakes Partners — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

InnovHeartinnovheart.comJan 2022 · $55M

InnovHeart develops the Saturn Transcatheter Mitral Valve Replacement (TMVR) system, a trans-septal mitral valve bioprosthesis used in interventional cardiology to treat mitral valve disease.

HealthtechMedical Devices

David James Wilson(Chief Executive Officer)

Co-investorsCDP Venture Capital Indaco Venture Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.